Cereon

Cereon Biotechnology is an Alaska-based biotechnology company focused on developing epigenetic intervention and prevention strategies to protect cognitive health. The company leverages the ethnobotanical pharmacopeia of the boreal forest and arctic tundra to identify natural compounds that blunt inflammatory and oxidative stress in the aging central nervous system. Its discovery platform specifically targets the protein-lipid interface to create novel nutraceuticals and phytochemical-inspired proprietary lead compounds. Cereon collaborates with the University of Alaska Fairbanks and utilizes SBIR grants to advance its research into Alzheimer's disease and other neurodegenerative conditions.